Brain Cancer Drug, Avastin, Not Approved for Provincial Funding

It boggles the mind, as I’ve said so many times before. But I’ll say it again, this time in reference to a conversation I had earlier this week with a senior Ontario Ministry of Health bureaucrat, about provincial funding for a relatively new anti-cancer drug. The drug is Bevacizumab. That’s its generic name. It’s better known by its trade name Avastin. Continue reading